Fulgent Genetics Inc (FLGT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 65,111 | 54,677 | 97,473 | 84,076 | 58,348 |
| Marketable Securities | 246,595 | 251,018 | 326,681 | 383,726 | 400,083 |
| Receivables | 56,573 | 52,060 | 51,132 | 49,277 | 34,809 |
| Other current assets | 30,825 | 28,754 | 32,559 | 32,776 | 35,049 |
| TOTAL | $399,104 | $386,509 | $507,845 | $549,855 | $528,289 |
| Non-Current Assets | |||||
| PPE Net | 93,368 | 86,723 | 83,464 | 85,265 | 87,556 |
| Investments And Advances | 526,163 | 540,495 | 423,571 | 383,659 | 388,383 |
| Intangibles | 161,028 | 163,044 | 165,108 | 286,333 | 288,443 |
| Other Non-Current Assets | 52,576 | 53,114 | 55,340 | 53,286 | 61,906 |
| TOTAL | $833,135 | $843,376 | $727,483 | $808,543 | $826,288 |
| Total Assets | $1,232,239 | $1,229,885 | $1,235,328 | $1,358,398 | $1,354,577 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 19,873 | 19,616 | 15,360 | 15,772 | 20,607 |
| Accrued Expenses | 26,425 | 25,918 | 30,737 | 21,031 | 22,229 |
| Other current liabilities | 29,041 | 30,002 | 25,738 | 21,728 | 17,423 |
| TOTAL | $75,751 | $75,949 | $73,018 | $61,421 | $64,819 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 21,072 | 20,269 | 27,247 | 25,669 | 26,793 |
| TOTAL | $27,640 | $27,290 | $29,024 | $35,143 | $26,432 |
| Total Liabilities | $103,391 | $103,239 | $102,042 | $96,564 | $91,251 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 30,297 | 29,924 | 29,785 | 29,633 | 29,927 |
| Common Shares | 3 | 3 | 3 | 3 | 3 |
| Retained earnings | 611,003 | 619,713 | 633,175 | 761,324 | 774,431 |
| Other shareholders' equity | -4,578 | -4,399 | -1,610 | -13,755 | -17,183 |
| TOTAL | $1,128,848 | $1,126,646 | $1,133,286 | $1,261,834 | $1,263,326 |
| Total Liabilities And Equity | $1,232,239 | $1,229,885 | $1,235,328 | $1,358,398 | $1,354,577 |